Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Apr 06, 2004 12:31am
452 Views
Post# 7319465

RE: Hey bilo, what's the market tellin'ya now?

RE: Hey bilo, what's the market tellin'ya now?Of course, the appointment of that director could not have been the "anticipated news" that was making the stock rise faster than...well, use your own imagination. Therefore, the release of that news should not have had the usual effect, nonetheless, it did well, reading between the transparent lines, this appointment certainly is at least suggestive of a potential partner, and perhaps much of the buying over recent weeks has been in anticipation of this "development". i don't think the gains are over, unless today's volume represents a climax - imo, it doesn't, since this appointment creates some anticipation (perhaps unrealistic) for the other shoe (ie., partnership) to drop. it isn't surprising though that the faster and steeper the climb, the greater the likelihood for profit-taking and a pullback (except apparently to bigwhino and his alias friends, who apparently are very watchful, sharing their "insights" here, but still can't figure out what is going on.
Bullboard Posts